Article
Cross‐immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147
16 Jan 2009
Abstract excerpt
Lantibiotics are antimicrobial peptides that possess great potential as clinical therapeutic agents. These peptides exhibit many beneficial traits and in many cases the emergence of resistance is extremely rare. In contrast, producers of lantibiotics synthesize dedicated immunity proteins to provide self-protection. These proteins have very specific activities and cross-immunity is rare. However, producers of two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
